1-16 of 16
Peter J. Browett
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Update of the Ascend-CML Study of Frontline Asciminib: High Rate of Optimal Response and Resistance Due to Mutations Is Rare

David T Yeung, Naranie Shanmuganathan, Agnes S. M. Yong, Jake Shortt, Lynette C.Y. Chee, Nicholas Vialla, Ilona Cunningham, David M Ross, Alwyn D'Souza, Matthew P.F. Wright, Rosemary Harrup, Cecily Forsyth, Robin Filshie, Steven W Lane, Peter J. Browett, Carolyn S. Grove, Mannu Walia, Susan Branford, John Reynolds, Andrew P Grigg, Timothy P Hughes
Journal: Blood
Blood (2024) 144 (Supplement 1): 476.
https://doi.org/10.1182/blood-2024-201218
Published: 2024
Journal Articles

A Phase II Randomized Trial Comparing Low-Dose Cytarabine and Venetoclax +/- Midostaurin in Non-Adverse Cytogenetic Risk Acute Myeloid Leukemia: The ALLG AMLM25 Intervene Trial

Chong Chyn Chua, Blake Hsu, Anoop K Enjeti, Ashish Bajel, Paula Marlton, Shaun Fleming, Devendra Hiwase, Chun Kei Kris Ma, Peter J. Browett, Travis Perera, Carolyn S. Grove, Shuhying Tan, Jad Othman, Julian Cooney, Hannah Rose, Edward S Morris, Rachel Koldej, David S. Ritchie, Kate Mason, Natasha S. Anstee, John Reynolds, Andrew H Wei
Journal: Blood
Blood (2024) 144 (Supplement 1): 217.
https://doi.org/10.1182/blood-2024-199882
Published: 2024
Journal Articles

Signaling Pathway Mutations Cooperate with the PICALM/MLLT10 Fusion in a Knock-in AML Mouse Model

Rhea H. Desai, Peter J. Browett, Purvi M. Kakadia, Stefan K. Bohlander
Journal: Blood
Blood (2023) 142 (Supplement 1): 4128.
https://doi.org/10.1182/blood-2023-178915
Published: 2023
Journal Articles

Picalm/MLLT10 Expression in Zebrafish Is Associated with an Increase of Hematopoietic Stem Cells and Leads to Leukemia

Omid Delfi, Peter J. Browett, Maryam Saberi, Yih Jian Sung, Purvi M. Kakadia, Stefan K. Bohlander
Journal: Blood
Blood (2023) 142 (Supplement 1): 5698.
https://doi.org/10.1182/blood-2023-179490
Published: 2023
Journal Articles

Drug Repurposing in a Zebrafish AML Model

Maryam Saberi, Omid Delfi, Peter J. Browett, Purvi M. Kakadia, Stefan K. Bohlander
Journal: Blood
Blood (2023) 142 (Supplement 1): 5763.
https://doi.org/10.1182/blood-2023-180293
Published: 2023
Journal Articles

Excellent Early and Major Molecular Responses Observed with Asciminib Treatment for CP-CML: Results from the ALLG CML13 Ascend-CML Study

David T Yeung, Naranie Shanmuganathan, John Reynolds, Susan Branford, Mannu Walia, Agnes S. M. Yong, Jake Shortt, Kate Burbury, Lynette C.Y. Chee, Nick Viiala, Ilona Cunningham, David M. Ross, Alwyn Bernard D'Souza, Matthew P.F. Wright, Rosemary Anne Harrup, Cecily Forsyth, Robin Filshie, Peter J. Browett, Steven W. Lane, Carolyn Grove, Andrew P Grigg, Timothy P Hughes, on Behalf Of The ALLG
Journal: Blood
Blood (2023) 142 (Supplement 1): 865.
https://doi.org/10.1182/blood-2023-172583
Published: 2023
Journal Articles

Early and Deep Molecular Responses Achieved with Frontline Asciminib in Chronic Phase CML - Interim Results from ALLG CML13 Ascend-CML

David T Yeung, Naranie Shanmuganathan, John Reynolds, Susan Branford, Mannu Walia, Agnes S.M. Yong, Jake Shortt, Kate Burbury, Nicholas Viiala, Ilona Cunningham, David M. Ross, Rosemary Harrup, Matthew Wright, Cecily Forsyth, Alwyn Bernard D'Souza, Robin J Filshie, Peter J. Browett, Steven W Lane, Carolyn Grove, Andrew Grigg, Timothy Hughes
Journal: Blood
Blood (2022) 140 (Supplement 1): 192–194.
https://doi.org/10.1182/blood-2022-157244
Published: 2022
Journal Articles

Vemircopan (ALXN2050) Monotherapy in Paroxysmal Nocturnal Hemoglobinuria: Interim Data from a Phase 2 Open-Label Proof-of-Concept Study

Peter J. Browett, Austin Kulasekararaj, Rosario Notaro, Masayo Ogawa, Antonio Risitano, Ji Yu, Jong Wook Lee
Journal: Blood
Blood (2022) 140 (Supplement 1): 717–719.
https://doi.org/10.1182/blood-2022-169301
Published: 2022
Journal Articles

Long-Term Efficacy and Safety of Zanubrutinib in Patients with Relapsed/Refractory (R/R) Marginal Zone Lymphoma (MZL): Final Analysis of the Magnolia (BGB-3111-214) Trial

Stephen Opat, Alessandra Tedeschi, Bei Hu, Kim M. Linton, Pamela McKay, Henry Chan, Jie Jin, Mingyuan Sun, Magdalena Sobieraj-Teague, Pier Luigi Zinzani, Peter J. Browett, Xiaoyan Ke, Craig A. Portell, Catherine Thieblemont, Kirit Ardeshna, Fontanet Bijou, Patricia Walker, Eliza Hawkes, Shir-Jing Ho, Keshu Zhou, Zhiyu Liang, Jianfeng Xu, Chris Tankersley, Richard Delarue, Melannie Co, Judith Trotman
Journal: Blood
Blood (2022) 140 (Supplement 1): 573–576.
https://doi.org/10.1182/blood-2022-163371
Published: 2022
Journal Articles

A Phase 1 Study with the Novel B-Cell Lymphoma 2 (Bcl-2) Inhibitor Bgb-11417 As Monotherapy or in Combination with Zanubrutinib (ZANU) in Patients (Pts) with CLL/SLL: Preliminary Data

Chan Y. Cheah, Constantine S. Tam, Masa Lasica, Emma Verner, Peter J. Browett, Mary Ann Anderson, James Hilger, Yiqian Fang, David Simpson, Stephen Opat
Journal: Blood
Blood (2022) 140 (Supplement 1): 2321–2323.
https://doi.org/10.1182/blood-2022-169662
Published: 2022
Journal Articles

Clonal Evolution in a Murine CALM-AF10 Leukemia: Evidence of Functional Heterogeneity of Leukemia Stem Cells

Niloofar Zandvakili, Hui Mei Lee, Rhea Desai, Alyona Oryshchuk, Peter J. Browett, Purvi M Kakadia, Stefan K. Bohlander
Journal: Blood
Blood (2021) 138 (Supplement 1): 1158.
https://doi.org/10.1182/blood-2021-154068
Published: 2021
Journal Articles

Preliminary Safety and Efficacy Data from Patients (Pts) with Relapsed/Refractory (R/R) B-Cell Malignancies Treated with the Novel B-Cell Lymphoma 2 (BCL2) Inhibitor BGB-11417 in Monotherapy or in Combination with Zanubrutinib

Constantine S. Tam, Emma Verner, Masa Lasica, Alejandro Arbelaez, Peter J. Browett, Jacob D. Soumerai, James Hilger, Yiqian Fang, Jane Huang, David Simpson, Stephen Opat, Chan Yoon Y. Cheah
Journal: Blood
Blood (2021) 138 (Supplement 1): 1419.
https://doi.org/10.1182/blood-2021-148451
Published: 2021
Journal Articles

MLL/AF9 Expression Causes Leukemia in Zebrafish

Maryam Saberi, Omid Delfi, Dona Wathsala Madola, Peter J. Browett, Purvi M Kakadia, Stefan K. Bohlander
Journal: Blood
Blood (2021) 138 (Supplement 1): 4330.
https://doi.org/10.1182/blood-2021-154125
Published: 2021
Journal Articles

Characterization of an Acute Myeloid Leukemia Murine Model Driven By MLL/AF9: Effect of Retroviral Insertion Sites and Somatic Mutations on Gene Expression

Hui Mei Lee, Niloofar Zandvakili, Rhea Desai, Peter J. Browett, Purvi M Kakadia, Stefan K. Bohlander
Journal: Blood
Blood (2021) 138 (Supplement 1): 4329.
https://doi.org/10.1182/blood-2021-154012
Published: 2021
Journal Articles

Fusion of Platelet-Derived Growth Factor β to a Novel Gene KIAA1509 on Chromosome 14 in an Atypical Myeloproliferative Disorder Associated with Eosinophilia.

Peter J. Browett, MBChB, Anna O’Grady, MSc, Paul Oei, MSc, Duncan Holdsworth, MSc, Neil S. Van de Water, PhD
Journal: Blood
Blood (2004) 104 (11): 2437.
https://doi.org/10.1182/blood.V104.11.2437.2437
Published: 2004
Journal Articles

The Utility of Peripheral Blood FISH in the Quantitation of BCR/ABL in CML Patients on Imatinib Mesylate: A Comparison with Bone Marrow FISH and Conventional Cytogenetics.

Samar Issa, MBChB, Duncan Holdsworth, MSc, Paul Oei, MSc, Peter J. Browett, MBChB
Journal: Blood
Blood (2004) 104 (11): 2942.
https://doi.org/10.1182/blood.V104.11.2942.2942
Published: 2004